1. Home
  2. Analysis

Hyperventilation and drugs of ingredients of telmisartan (a real world drug study)


Summary:

Hyperventilation is found among people who take drugs with ingredients of telmisartan, especially for people who are male, 60+ old . This phase IV clinical study is created by eHealthMe based on reports of 34,958 people who have side effects when taking drugs with ingredients of telmisartan from the FDA, and is updated regularly.

Drug(s) considered in the study (i.e. both brand name and generic drugs): Micardis, Telmisartan.

On Apr, 16, 2026

34,958 people reported to have side effects when taking drugs with ingredients of telmisartan.
Among them, 25 people (0.07%) have Hyperventilation

What is Hyperventilation?

Hyperventilation is found to be associated with 738 drugs and 1,442 conditions by eHealthMe. Check the latest studies of Hyperventilation.

Number of reports submitted per year:

Could drugs with ingredients of telmisartan cause Hyperventilation?

Gender of people who have Hyperventilation when taking drugs with ingredients of telmisartan *:

  • female: 40.91 %
  • male: 59.09 %

Age of people who have Hyperventilation when taking drugs with ingredients of telmisartan *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 11.11 %
  • 30-39: 0.0 %
  • 40-49: 22.22 %
  • 50-59: 22.22 %
  • 60+: 44.44 %

Conditions people have *:

You may use this to check any potential undetected conditions.

  1. Type 2 Diabetes: 12 people, 48.00%
  2. Stress And Anxiety: 5 people, 20.00%
  3. Heart Disease: 3 people, 12.00%
  4. Cerebral Disorder (brain disease): 3 people, 12.00%
  5. Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 3 people, 12.00%
  6. Diabetes: 3 people, 12.00%
  7. Gastric Ulcer (stomach ulcer): 3 people, 12.00%
  8. High Blood Cholesterol: 3 people, 12.00%
  9. Neurogenic Bladder (the normal function of the bladder is to store and empty urine in a coordinated, controlled fashion): 2 people, 8.00%
  10. Hiatal Hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm): 2 people, 8.00%

Other drugs people take *:

You may use this to check any potential interacting drugs.

  1. Metformin Hydrochloride: 10 people, 40.00%
  2. Jardiance: 9 people, 36.00%
  3. Ibuprofen: 9 people, 36.00%
  4. Victoza: 9 people, 36.00%
  5. Esomeprazole Magnesium: 9 people, 36.00%
  6. Valsartan: 9 people, 36.00%
  7. Albuterol Sulfate: 9 people, 36.00%
  8. Amlodipine Besylate: 9 people, 36.00%
  9. Torsemide: 9 people, 36.00%
  10. Lyrica: 9 people, 36.00%

Other side effects people have besides Hyperventilation *:

You may use this to check any potential undetected side effects.

  1. Drowsiness: 15 people, 60.00%
  2. Weakness: 14 people, 56.00%
  3. Feeling Abnormal: 14 people, 56.00%
  4. Chest Pain: 14 people, 56.00%
  5. Fatigue (feeling of tiredness): 14 people, 56.00%
  6. Heart Palpitations (feelings or sensations that your heart is pounding or racing): 13 people, 52.00%
  7. Headache (pain in head): 12 people, 48.00%
  8. Joint Pain: 12 people, 48.00%
  9. Depression: 11 people, 44.00%
  10. Mental Disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability): 11 people, 44.00%

* Approximation only. Some reports may have incomplete information.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related publications that referenced our studies

Related studies

Drugs with ingredients of telmisartan, their effectiveness, alternatives and more:

How the study uses the data?

The study uses data from the FDA. It is based on telmisartan. All drugs that have the same active ingredients (e.g. brand name and generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.